Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Outset Medical (OM)
NASDAQ:OM
Earnings Data
Report Date
Apr 30, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.3Last Year’s EPS
-0.57Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 19, 2025
|% Change Since: 2.13%
|Next Earnings Date:Apr 30, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong recurring revenue growth and significant operational improvements, including gross margin expansion and successful recapitalization. However, challenges remain in console sales and meeting original revenue expectations.Company Guidance
During the Outset Medical Fourth Quarter 2024 Earnings Conference Call, several key metrics and forward-looking guidance were highlighted. The company reported a quarterly revenue of $29.5 million, beating earlier expectations, and closing the fiscal year with $113.7 million in revenue. Recurring revenue saw a 13% sequential increase, reaching $23.7 million for the quarter, and a 21% growth for the full year, totaling $83.9 million. The installed base of Tablo consoles grew by 10% year-over-year, with nearly 6,000 units deployed, leading to an anticipated recurring revenue run rate of over $100 million by the end of 2025. Gross margin expanded to 37.6% in Q4, with expectations to reach above 40% by the end of 2025, despite the impact of under-absorption of manufacturing overhead. Operating expenses decreased by 27% year-over-year to $26.6 million in Q4. Looking ahead, Outset Medical anticipates 2025 revenue between $115 million and $125 million, with a continued focus on growing the console installed base, expanding gross margins, and achieving profitability.Strong Recurring Revenue Growth
Recurring revenue grew 13% sequentially and 17% year-over-year, driven by strong utilization across the installed base of nearly 6,000 Tablo consoles.
Gross Margin Expansion
Non-GAAP gross margin expanded by nearly 12 percentage points in 2024, with a continued focus on reaching above 40% in 2025.
Successful Recapitalization
Outset Medical secured $172.7 million in equity financing and reduced their outstanding debt from $200 million to $100 million, extending the maturity to 2030.
Regulatory Achievement
The FDA warning letter from July 2023 was officially closed following a comprehensive inspection with no 483 observations.
Operational Cost Reductions
Operating expenses decreased by 27%, and the company plans to reduce cash use in 2025 by more than 50% compared to 2024.
---
OM Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
OM Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 19, 2025 | $0.94 | $0.96 | +2.13% |
| Nov 06, 2024 | $0.62 | $0.78 | +25.81% |
| Aug 07, 2024 | $3.40 | $1.07 | -68.53% |
| May 08, 2024 | $4.13 | $3.27 | -20.82% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Outset Medical (OM) report earnings?
Outset Medical (OM) is schdueled to report earning on Apr 30, 2025, TBA Not Confirmed.
What is Outset Medical (OM) earnings time?
Outset Medical (OM) earnings time is at Apr 30, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is OM EPS forecast?
OM EPS forecast for the fiscal quarter 2025 (Q1) is -0.3.
---